Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Council Recommends More Medicare Cost-Sharing To Supercommittee

This article was originally published in The Gray Sheet

Executive Summary

A health care industry coalition Sept. 14 said it will advise Congress’ deficit-reducing “supercommittee” to create a more uniform cost-sharing structure, including the potential addition of new patient deductibles and co-pays in areas such as laboratory services.

You may also be interested in...



In Deficit Reduction, Medicare Cost-Shifting Is Not The Way To Go – Panel

Congress needs to consider the health care system as a whole and not just one-off Medicare cuts as it works to reduce the deficit, health policy leaders stressed during an Oct. 11 panel discussion in Washington, D.C.

In Deficit Reduction, Medicare Cost-Shifting Is Not The Way To Go – Panel

Congress needs to consider the health care system as a whole and not just one-off Medicare cuts as it works to reduce the deficit, health policy leaders stressed during an Oct. 11 panel discussion in Washington, D.C.

Usual Suspects: President’s Deficit Reduction Plans Include Imaging, Durable Equipment Cuts

President Obama’s plan for reducing the deficit, released Sept. 19, recycles concepts the administration has previously floated to reduce spending on advanced imaging and lower durable medical equipment Medicaid payment rates.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030547

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel